Third Rock Ventures Gp Iii, L.p. - Net Worth and Insider Trading

Over the past 18 months, Third Rock Ventures Gp Iii, L.p. made no insider transaction in Revolution Medicines Inc (RVMD). Other recent insider transactions involving Revolution Medicines Inc (RVMD) include a net sale of 34,044 shares made by Jeff Cislini , a net sale of 186,391 shares made by Stephen Michael Kelsey , and a net sale of 265,672 shares made by Mark A Goldsmith .

In summary, during the past 3 months, insiders sold 249,942 shares of Revolution Medicines Inc (RVMD) in total and bought 0 shares, with a net sale of 249,942 shares. During the past 18 months, 718,995 shares of Revolution Medicines Inc (RVMD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 718,995 shares.

Revolution Medicines Inc (RVMD)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Third Rock Ventures Gp Iii, L.p. made no insider transaction in Nurix Therapeutics Inc (NRIX). Other recent insider transactions involving Nurix Therapeutics Inc (NRIX) include a net sale of 67,327 shares made by Christine Ring , a net sale of 82,022 shares made by Houte Hans Van , and a net sale of 14,703 shares made by Gwenn Hansen .

In summary, during the past 3 months, insiders sold 70,553 shares of Nurix Therapeutics Inc (NRIX) in total and bought 0 shares, with a net sale of 70,553 shares. During the past 18 months, 164,052 shares of Nurix Therapeutics Inc (NRIX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 164,052 shares.

Nurix Therapeutics Inc (NRIX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Third Rock Ventures Gp Iii, L.p. made no insider transaction in Relay Therapeutics Inc (RLAY). Other recent insider transactions involving Relay Therapeutics Inc (RLAY) include a net sale of 132,111 shares made by Peter Rahmer , a net sale of 44,032 shares made by Thomas Catinazzo , and a net sale of 18,539 shares made by Donald A Bergstrom .

In summary, during the past 3 months, insiders sold 22,688 shares of Relay Therapeutics Inc (RLAY) in total and bought 0 shares, with a net sale of 22,688 shares. During the past 18 months, 291,361 shares of Relay Therapeutics Inc (RLAY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 291,361 shares.

Relay Therapeutics Inc (RLAY)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Third Rock Ventures Gp Iii, L.p. made no insider transaction in Pliant Therapeutics Inc (PLRX). Other recent insider transactions involving Pliant Therapeutics Inc (PLRX) include a net sale of 72,542 shares made by Hans Hull , a net sale of 30,386 shares made by Mike Ouimette , and a net sale of 134,581 shares made by Bernard Coulie .

In summary, during the past 3 months, insiders sold 0 shares of Pliant Therapeutics Inc (PLRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 322,907 shares of Pliant Therapeutics Inc (PLRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 322,907 shares.

Pliant Therapeutics Inc (PLRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Third Rock Ventures Gp Iii, L.p. made no insider transaction in Fulcrum Therapeutics Inc (FULC). Other recent insider transactions involving Fulcrum Therapeutics Inc (FULC) include a net sale of 5,120 shares made by Greg Tourangeau , and a net purchase of 43,360 shares made by Alex Sapir .

In summary, during the past 3 months, insiders sold 0 shares of Fulcrum Therapeutics Inc (FULC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 5,120 shares of Fulcrum Therapeutics Inc (FULC) were sold and 43,360 shares were bought by its insiders, resulting in a net purchase of 38,240 shares.

Fulcrum Therapeutics Inc (FULC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Third Rock Ventures Gp Iii, L.p. made no insider transaction in Voyager Therapeutics Inc (VYGR). Other recent insider transactions involving Voyager Therapeutics Inc (VYGR) include a net sale of 21,233 shares made by Todd Alfred Carter , a net sale of 7,866 shares made by Robin Swartz , and a net sale of 25,148 shares made by Alfred Sandrock .

In summary, during the past 3 months, insiders sold 5,999 shares of Voyager Therapeutics Inc (VYGR) in total and bought 0 shares, with a net sale of 5,999 shares. During the past 18 months, 77,577 shares of Voyager Therapeutics Inc (VYGR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 77,577 shares.

Voyager Therapeutics Inc (VYGR)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Neon Therapeutics Inc (NTGN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Neon Therapeutics Inc (NTGN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Neon Therapeutics Inc (NTGN)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of MyoKardia Inc (MYOK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of MyoKardia Inc (MYOK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

MyoKardia Inc (MYOK)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Global Blood Therapeutics Inc (GBT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Global Blood Therapeutics Inc (GBT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Global Blood Therapeutics Inc (GBT)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Jounce Therapeutics Inc (JNCE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Jounce Therapeutics Inc (JNCE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Jounce Therapeutics Inc (JNCE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Third Rock Ventures Gp Iii, L.p. made no insider transaction in Editas Medicine Inc (EDIT). Other recent insider transactions involving Editas Medicine Inc (EDIT) include a net sale of 1,988 shares made by Bruce Eaton , a net sale of 32,292 shares made by Baisong Mei , and a net sale of 98,056 shares made by Gilmore Neil O'neill .

In summary, during the past 3 months, insiders sold 2,073 shares of Editas Medicine Inc (EDIT) in total and bought 0 shares, with a net sale of 2,073 shares. During the past 18 months, 166,559 shares of Editas Medicine Inc (EDIT) were sold and 45,000 shares were bought by its insiders, resulting in a net sale of 121,559 shares.

Editas Medicine Inc (EDIT)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Decibel Therapeutics Inc (DBTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Decibel Therapeutics Inc (DBTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Decibel Therapeutics Inc (DBTX)'s detailed insider trading history can be found in Insider Trading Tracker table.